Literature DB >> 9194623

Localization of T cells, interferon-gamma and HLA-DR in eutopic and ectopic human endometrium.

C M Chiang1, J A Hill.   

Abstract

OBJECTIVES: Immunologic mechanisms are implicated in the pathogenesis of endometriosis and endometriosis-associated reproductive failure. The purpose of this study was to describe key immune response elements in eutopic and ectopic endometrium and to test the hypothesis that expression of CD3-positive T cells, the T-helper 1-type cytokine, IFN-gamma, and the antigen presentation marker, HLA-DR, vary throughout the menstrual cycle in eutopic endometrium and are more abundantly expressed in ectopic than in eutopic endometrium.
METHODS: Eutopic and ectopic endometrium obtained at hysterectomy from 7 women with endometriosis were compared with hysterectomy specimens from 7 women with adenomyosis and 10 women without endometriosis or endometrial pathology. Tissues were formalin-fixed, paraffin-embedded, sectioned and stained using the biotin-streptavidin-alkaline phosphatase technique and antibodies to human CD3, IFN-gamma, and HLA-DR. Eutopic endometrial samples were histologically divided into menses (n = 5), proliferative (n = 9), and secretory (n = 10) phases. Positive control tissues (spleen) and negative controls (no primary antibody) were used in each experiment.
RESULTS: T cells, IFN-gamma and HLA-DR-positive cells were observed in eutopic endometrial samples throughout the menstrual cycle. Glandular epithelium was CD3-negative except for CD3-positive cells surrounding and occasionally interdigitating between glandular epithelium. Glandular epithelium was IFN-gamma-positive and HLA-DR-positive in all phases except the proliferative phase. Staining was more often observed in the basalis than in the functionalis layer, ranging from patchy staining to the entire gland. T cells, IFN-gamma, and HLA-DR-positive stromal cells were more abundant in secretory endometrium than in proliferative samples. CD3, IFN-gamma, and HLA-DR-positive cells were scattered throughout the myometrium and concentrated in vessels. Higher intensity staining was observed in ectopic than in eutopic endometrium, with CD3 and HLA-DR-positive cells forming aggregates around IFN-gamma and HLA-DR-positive glands. The intensity of IFN-gamma staining in ectopic endometrium was similar to the intensity of staining observed in menstrual and late secretory basalis samples from eutopic endometrium.
CONCLUSIONS: The results of this observational study suggest that activated T cells, IFN-gamma and upregulation of antigen presentation may play a role in normal endometrial physiology. The increased number of T cells, expression of IFN-gamma, and enhanced antigen presentation in ectopic compared to eutopic endometrium support the concept that cellular immune activation is involved in endometriosis and its sequelae.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194623     DOI: 10.1159/000291866

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

Review 2.  The Role of the Immune System in the Development of Endometriosis.

Authors:  Monika Abramiuk; Ewelina Grywalska; Paulina Małkowska; Olga Sierawska; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

3.  RBPJ mediates uterine repair in the mouse and is reduced in women with recurrent pregnancy loss.

Authors:  Michael R Strug; Ren-Wei Su; Tae Hoon Kim; Alessandro Mauriello; Carlo Ticconi; Bruce A Lessey; Steven L Young; Jeong Mook Lim; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

4.  Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls.

Authors:  Tamara Knific; Dmytro Fishman; Andrej Vogler; Manuela Gstöttner; René Wenzl; Hedi Peterson; Tea Lanišnik Rižner
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.